These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 18613218

  • 1. Plasma glycooxidation protein products in type 2 diabetic patients with nephropathy.
    Piwowar A, Knapik-Kordecka M, Szczecińska J, Warwas M.
    Diabetes Metab Res Rev; 2008 Oct; 24(7):549-53. PubMed ID: 18613218
    [Abstract] [Full Text] [Related]

  • 2. The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy.
    Shimoike T, Inoguchi T, Umeda F, Nawata H, Kawano K, Ochi H.
    Metabolism; 2000 Aug; 49(8):1030-5. PubMed ID: 10954022
    [Abstract] [Full Text] [Related]

  • 3. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.
    Awadallah SM, Saleh SA, Abu Shaqra QM, Hilow H.
    J Diabetes Complications; 2008 Aug; 22(6):384-8. PubMed ID: 18413152
    [Abstract] [Full Text] [Related]

  • 4. [Advanced oxidation protein products in diabetic nephropathy patients and its relation with superoxide dismutase, glutathione peroxidase, neopterin].
    Wu ZX, Xue YM, Li CZ, Guan MP.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 30(6):704-7. PubMed ID: 16708815
    [Abstract] [Full Text] [Related]

  • 5. [Oxidative stress and endothelium dysfunction in diabetes mellitus type 2].
    Piwowar A, Knapik-Kordecka M, Warwas M.
    Pol Merkur Lekarski; 2008 Aug; 25(146):120-3. PubMed ID: 18942329
    [Abstract] [Full Text] [Related]

  • 6. Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.
    Kim NH, Kim KB, Kim DL, Kim SG, Choi KM, Baik SH, Choi DS, Kang YS, Han SY, Han KH, Ji YH, Cha DR.
    Diabet Med; 2004 Jun; 21(6):545-51. PubMed ID: 15154937
    [Abstract] [Full Text] [Related]

  • 7. The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension.
    Busch M, Franke S, Wolf G, Brandstädt A, Ott U, Gerth J, Hunsicker LG, Stein G, Collaborative Study Group.
    Am J Kidney Dis; 2006 Oct; 48(4):571-9. PubMed ID: 16997053
    [Abstract] [Full Text] [Related]

  • 8. [The total antioxidant capacity and low-molecular antioxidant concentration in plasma of type-2 diabetes patients with different stage of metabolic compensation and concomitant diabetic nephropathy].
    Błaszczak R, Kujawski K, Kedziora-Kornatowska K, Kornatowski T, Kedziora J, Szadujkis-Szadurski L, Markuszewski L, Rysz J, Ertel D, Olszewski R.
    Pol Merkur Lekarski; 2005 Jan; 18(103):29-32. PubMed ID: 15859542
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Elevation of urinary betaig-h3, transforming growth factor-beta-induced protein in patients with type 2 diabetes and nephropathy.
    Ha SW, Kim HJ, Bae JS, Jeong GH, Chung SC, Kim JG, Park SH, Kim YL, Kam S, Kim IS, Kim BW.
    Diabetes Res Clin Pract; 2004 Aug; 65(2):167-73. PubMed ID: 15223229
    [Abstract] [Full Text] [Related]

  • 12. Does renal function influence plasma levels of advanced glycation and oxidation protein products in patients with chronic rheumatic diseases complicated by secondary amyloidosis?
    Rysavá R, Kalousová M, Zima T, Dostál C, Merta M, Tesar V.
    Kidney Blood Press Res; 2007 Aug; 30(1):1-7. PubMed ID: 17191033
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Markers of oxidative protein damage in plasma and urine of type 2 diabetic patients.
    Piwowar A, Knapik-Kordecka M, Warwas M.
    Br J Biomed Sci; 2009 Aug; 66(4):194-9. PubMed ID: 20095128
    [Abstract] [Full Text] [Related]

  • 19. Elevated plasma atrial natriuretic peptide level in the early phase of microalbuminuria in patients with non-insulin-dependent diabetes mellitus.
    Shinoda T, Ishihara M, Kurimoto F, Aizawa T, Hiramatsu K, Shirota T, Takasu N, Yamada T.
    Clin Nephrol; 1990 Nov; 34(5):202-7. PubMed ID: 2148510
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.